Yuki Hamano

2.6k total citations
27 papers, 2.0k citations indexed

About

Yuki Hamano is a scholar working on Molecular Biology, Nephrology and Immunology and Allergy. According to data from OpenAlex, Yuki Hamano has authored 27 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Nephrology and 4 papers in Immunology and Allergy. Recurrent topics in Yuki Hamano's work include Renal Diseases and Glomerulopathies (5 papers), Angiogenesis and VEGF in Cancer (5 papers) and Cell Adhesion Molecules Research (4 papers). Yuki Hamano is often cited by papers focused on Renal Diseases and Glomerulopathies (5 papers), Angiogenesis and VEGF in Cancer (5 papers) and Cell Adhesion Molecules Research (4 papers). Yuki Hamano collaborates with scholars based in Japan, United States and United Kingdom. Yuki Hamano's co-authors include Raghu Kalluri, Hikaru Sugimoto, Akulapalli Sudhakar, Mark W. Kieran, Dominic Cosgrove, David M. Charytan, Michael Zeisberg, Richard O. Hynes, Changqing Yang and Yohei Maeshima and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Yuki Hamano

25 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuki Hamano Japan 15 814 466 460 396 365 27 2.0k
Peter W. Hewett United Kingdom 24 988 1.2× 629 1.3× 231 0.5× 422 1.1× 458 1.3× 42 2.0k
Camila Avivi Israel 24 650 0.8× 126 0.3× 349 0.8× 538 1.4× 96 0.3× 53 1.7k
Bernhard Barleon Germany 14 1.3k 1.6× 202 0.4× 577 1.3× 166 0.4× 101 0.3× 17 1.7k
Hervé Sartelet France 23 807 1.0× 46 0.1× 377 0.8× 246 0.6× 73 0.2× 82 1.7k
Bryan L. Wharram United States 25 1.1k 1.3× 55 0.1× 115 0.3× 552 1.4× 113 0.3× 33 3.0k
Joshua I. Greenberg United States 12 614 0.8× 86 0.2× 287 0.6× 229 0.6× 86 0.2× 26 1.4k
Gilbert O’Young United States 12 726 0.9× 188 0.4× 172 0.4× 184 0.5× 154 0.4× 22 1.4k
Kazuo Matsui Japan 19 995 1.2× 161 0.3× 150 0.3× 259 0.7× 117 0.3× 108 1.9k
Cecilia A. Fernández United States 15 864 1.1× 40 0.1× 554 1.2× 117 0.3× 44 0.1× 21 1.6k
Douglas Armellino United States 15 1.3k 1.6× 99 0.2× 401 0.9× 247 0.6× 40 0.1× 18 2.3k

Countries citing papers authored by Yuki Hamano

Since Specialization
Citations

This map shows the geographic impact of Yuki Hamano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuki Hamano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuki Hamano more than expected).

Fields of papers citing papers by Yuki Hamano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuki Hamano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuki Hamano. The network helps show where Yuki Hamano may publish in the future.

Co-authorship network of co-authors of Yuki Hamano

This figure shows the co-authorship network connecting the top 25 collaborators of Yuki Hamano. A scholar is included among the top collaborators of Yuki Hamano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuki Hamano. Yuki Hamano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hamano, Yuki, Kazuichi Maruyama, Yoshinori Oie, et al.. (2022). Novel corneal morphological alterations in Vogt-Koyanagi-Harada disease. Japanese Journal of Ophthalmology. 66(4). 358–364. 1 indexed citations
3.
Matsushita, Kenji, Noriyasu Hashida, Yuki Hamano, et al.. (2021). Barium-induced toxic anterior segment syndrome. European Journal of Ophthalmology. 33(3). NP31–NP35. 2 indexed citations
4.
Parchem, Jacqueline G., Keizo Kanasaki, Megumi Kanasaki, et al.. (2018). Loss of placental growth factor ameliorates maternal hypertension and preeclampsia in mice. Journal of Clinical Investigation. 128(11). 5008–5017. 38 indexed citations
5.
Sasaki, Naoko, Yasuo Okumura, Ichiro Watanabe, et al.. (2015). Frequency analysis of atrial fibrillation from the specific ECG leads V7–V9: A lower DF in lead V9 is a marker of potential atrial remodeling. Journal of Cardiology. 66(5). 388–394. 8 indexed citations
6.
Hamano, Yuki, et al.. (2011). Attenuation of Immune-Mediated Renal Injury by Telmisartan, an Angiotensin Receptor Blocker and a Selective PPAR-γ Activator. SHILAP Revista de lepidopterología. 1(1). 78–90. 6 indexed citations
7.
Hamano, Yuki, Ryota Shirai, Ryota Kimura, et al.. (2010). Lack of Collagen XVIII/Endostatin Exacerbates Immune-Mediated Glomerulonephritis. Journal of the American Society of Nephrology. 21(9). 1445–1455. 32 indexed citations
8.
Hamano, Yuki, Takahiro Aoki, Ryota Shirai, et al.. (2009). Low-Dose Darbepoetin α Attenuates Progression of a Mouse Model of Aristolochic Acid Nephropathy through Early Tubular Protection. Nephron Experimental Nephrology. 114(2). e69–e81. 18 indexed citations
9.
Kanasaki, Keizo, Kristin Palmsten, Hikaru Sugimoto, et al.. (2008). Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature. 453(7198). 1117–1121. 305 indexed citations
10.
Osawa, Tsutomu, et al.. (2008). Hydrogen–deuterium exchange of methane on nickel surface prepared by the reduction of nickel oxide. Journal of Molecular Catalysis A Chemical. 298(1-2). 111–114. 7 indexed citations
11.
Sund, Malin, Yuki Hamano, Hikaru Sugimoto, et al.. (2005). Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors. Proceedings of the National Academy of Sciences. 102(8). 2934–2939. 130 indexed citations
12.
Hamano, Yuki & Raghu Kalluri. (2005). Tumstatin, the NC1 domain of α3 chain of type IV collagen, is an endogenous inhibitor of pathological angiogenesis and suppresses tumor growth. Biochemical and Biophysical Research Communications. 333(2). 292–298. 95 indexed citations
13.
Hamano, Yuki, Michael Zeisberg, Hikaru Sugimoto, et al.. (2003). Physiological levels of tumstatin, a fragment of collagen IV α3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via αVβ3 integrin. Cancer Cell. 3(6). 589–601. 428 indexed citations
14.
Sugimoto, Hikaru, Yuki Hamano, David M. Charytan, et al.. (2003). Neutralization of Circulating Vascular Endothelial Growth Factor (VEGF) by Anti-VEGF Antibodies and Soluble VEGF Receptor 1 (sFlt-1) Induces Proteinuria. Journal of Biological Chemistry. 278(15). 12605–12608. 431 indexed citations
15.
Fujii, Takayuki, Yuki Hamano, Shiro Ueda, et al.. (2003). Predominant role of FcγRIII in the induction of accelerated nephrotoxic glomerulonephritis. Kidney International. 64(4). 1406–1416. 24 indexed citations
16.
Natoli, Thomas A., Jing Liu, Vera Eremina, et al.. (2002). A Mutant Form of the Wilms’ Tumor Suppressor Gene WT1 Observed in Denys-Drash Syndrome Interferes with Glomerular Capillary Development. Journal of the American Society of Nephrology. 13(8). 2058–2067. 46 indexed citations
17.
Hamano, Yuki, James A. Grunkemeyer, Akulapalli Sudhakar, et al.. (2002). Determinants of Vascular Permeability in the Kidney Glomerulus. Journal of Biological Chemistry. 277(34). 31154–31162. 101 indexed citations
18.
Hamano, Yuki, Hisashi Arase, Hiromitsu Saisho, & Takashi Saito. (2000). Immune Complex and Fc Receptor-Mediated Augmentation of Antigen Presentation for in Vivo Th Cell Responses. The Journal of Immunology. 164(12). 6113–6119. 76 indexed citations
19.
Yamazaki, Tetsuo, Yuki Hamano, Hironori Tashiro, et al.. (1999). CAST, a Novel CD3ε-binding Protein Transducing Activation Signal for Interleukin-2 Production in T Cells. Journal of Biological Chemistry. 274(26). 18173–18180. 40 indexed citations
20.
Ogihara, Takeshi, Mitsuaki Nakamaru, Jitsuo Higaki, et al.. (1987). PHASE-I STUDY OF A NEW ORALLY ACTIVE ANGIOTENSIN-I-CONVERTING ENZYME-INHIBITOR, DELAPRIL. Current Therapeutic Research. 41(6). 809–822. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter W. Hewett Breakdown of academic impact, for papers by Camila Avivi Breakdown of academic impact, for papers by Bernhard Barleon Breakdown of academic impact, for papers by Hervé Sartelet Breakdown of academic impact, for papers by Bryan L. Wharram Breakdown of academic impact, for papers by Joshua I. Greenberg Breakdown of academic impact, for papers by Gilbert O’Young Breakdown of academic impact, for papers by Kazuo Matsui Breakdown of academic impact, for papers by Cecilia A. Fernández Breakdown of academic impact, for papers by Douglas Armellino
Rankless by CCL
2026